Elevance Health Statistics
Total Valuation
Elevance Health has a market cap or net worth of $84.85 billion. The enterprise value is $105.66 billion.
| Market Cap | 84.85B |
| Enterprise Value | 105.66B |
Important Dates
The last earnings date was Wednesday, July 15, 2026, before market open.
| Earnings Date | Jul 15, 2026 |
| Ex-Dividend Date | Sep 10, 2026 |
Share Statistics
Elevance Health has 216.87 million shares outstanding. The number of shares has decreased by -3.64% in one year.
| Current Share Class | 216.87M |
| Shares Outstanding | 216.87M |
| Shares Change (YoY) | -3.64% |
| Shares Change (QoQ) | -1.13% |
| Owned by Insiders (%) | 0.12% |
| Owned by Institutions (%) | 94.95% |
| Float | 216.41M |
Valuation Ratios
The trailing PE ratio is 17.41 and the forward PE ratio is 14.44. Elevance Health's PEG ratio is 3.97.
| PE Ratio | 17.41 |
| Forward PE | 14.44 |
| PS Ratio | 0.42 |
| Forward PS | 0.43 |
| PB Ratio | 1.89 |
| P/TBV Ratio | 15.26 |
| P/FCF Ratio | 13.49 |
| P/OCF Ratio | 11.37 |
| PEG Ratio | 3.97 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.97, with an EV/FCF ratio of 16.80.
| EV / Earnings | 21.29 |
| EV / Sales | 0.53 |
| EV / EBITDA | 15.97 |
| EV / EBIT | 21.54 |
| EV / FCF | 16.80 |
Financial Position
The company has a current ratio of 1.52, with a Debt / Equity ratio of 0.69.
| Current Ratio | 1.52 |
| Quick Ratio | 1.37 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | 4.69 |
| Debt / FCF | 4.94 |
| Interest Coverage | 3.41 |
Financial Efficiency
Return on equity (ROE) is 11.13% and return on invested capital (ROIC) is 8.46%.
| Return on Equity (ROE) | 11.13% |
| Return on Assets (ROA) | 3.83% |
| Return on Invested Capital (ROIC) | 8.46% |
| Return on Capital Employed (ROCE) | 5.97% |
| Weighted Average Cost of Capital (WACC) | 6.95% |
| Revenue Per Employee | $2.07M |
| Profits Per Employee | $51,112 |
| Employee Count | 97,100 |
| Asset Turnover | 1.62 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Elevance Health has paid $915.00 million in taxes.
| Income Tax | 915.00M |
| Effective Tax Rate | 15.61% |
Stock Price Statistics
The stock price has increased by +42.31% in the last 52 weeks. The beta is 0.69, so Elevance Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | +42.31% |
| 50-Day Moving Average | 396.05 |
| 200-Day Moving Average | 351.67 |
| Relative Strength Index (RSI) | 51.44 |
| Average Volume (20 Days) | 1,476,025 |
Short Selling Information
The latest short interest is 6.03 million, so 2.78% of the outstanding shares have been sold short.
| Short Interest | 6.03M |
| Short Previous Month | 6.28M |
| Short % of Shares Out | 2.78% |
| Short % of Float | 2.78% |
| Short Ratio (days to cover) | 3.47 |
Income Statement
In the last 12 months, Elevance Health had revenue of $201.11 billion and earned $4.96 billion in profits. Earnings per share was $22.47.
| Revenue | 201.11B |
| Gross Profit | 52.27B |
| Operating Income | 7.61B |
| Pretax Income | 5.86B |
| Net Income | 4.96B |
| EBITDA | 6.62B |
| EBIT | 4.91B |
| Earnings Per Share (EPS) | $22.47 |
Balance Sheet
The company has $37.51 billion in cash and $31.04 billion in debt, with a net cash position of -$20.81 billion or -$95.97 per share.
| Cash & Cash Equivalents | 37.51B |
| Total Debt | 31.04B |
| Net Cash | -20.81B |
| Net Cash Per Share | -$95.97 |
| Equity (Book Value) | 45.02B |
| Book Value Per Share | 206.99 |
| Working Capital | 22.93B |
Cash Flow
In the last 12 months, operating cash flow was $7.46 billion and capital expenditures -$1.18 billion, giving a free cash flow of $6.29 billion.
| Operating Cash Flow | 7.46B |
| Capital Expenditures | -1.18B |
| Depreciation & Amortization | n/a |
| Net Borrowing | 546.00M |
| Free Cash Flow | 6.29B |
| FCF Per Share | $29.00 |
Margins
Gross margin is 25.99%, with operating and profit margins of 3.79% and 2.47%.
| Gross Margin | 25.99% |
| Operating Margin | 3.79% |
| Pretax Margin | 2.91% |
| Profit Margin | 2.47% |
| EBITDA Margin | 3.33% |
| EBIT Margin | 2.47% |
| FCF Margin | 3.13% |
Dividends & Yields
This stock pays an annual dividend of $6.88, which amounts to a dividend yield of 1.76%.
| Dividend Per Share | $6.88 |
| Dividend Yield | 1.76% |
| Dividend Growth (YoY) | 1.63% |
| Years of Dividend Growth | 14 |
| Payout Ratio | 30.61% |
| Buyback Yield | 3.64% |
| Shareholder Yield | 5.40% |
| Earnings Yield | 5.85% |
| FCF Yield | 7.41% |
Analyst Forecast
The average price target for Elevance Health is $449.10, which is 14.79% higher than the current price. The consensus rating is "Buy".
| Price Target | $449.10 |
| Price Target Difference | 14.79% |
| Analyst Consensus | Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (3Y) | 2.19% |
| EPS Growth Forecast (3Y) | 3.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 1, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 1, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |